Asthma Spacers Market Segmentation by Product Type - Aerochamber, Optichamber, Volumatic, Inspirease; Distribution Channel - Retail Pharmacy, Hospital Pharmacy, E-commerce, and Forecast 2018-2026
Sr. No. Chapter 1 Chapter 2 Chapter 3 Chapter 4 Chapter 5 Chapter 6 Chapter 7 Chapter 8 Chapter 9 Chapter 10 Chapter 11 Chapter 12 Chapter 13 Chapter 14 Content Preface Assumptions and Research Methodology Market Overview Market Dynamics Global Asthma Spacers Market Analysis and Forecasts, By Software Type Global Asthma Spacers Market Analysis, by Modality Global Asthma Spacers Market Analysis, by Application Global Asthma Spacers Market Analysis, by End-user Global Asthma Spacers Market Analysis and Forecast by Region Europe Asthma Spacers Market Analysis and Forecast Asia Pacific Asthma Spacers Market Analysis and Forecast Latin America Asthma Spacers Market Analysis and Forecast Middle East & Africa Asthma Spacers Market Analysis and Forecast Competition Landscape
Asthma is a chronic respiratory condition that affects millions of people around the world. Aerosol drug delivery is the first line administration route in asthma management, and metered dose inhalers (MDIs) are the most common type of inhalers used in asthmatic conditions. A spacer, usually attached with an MDI, is an external device that provides better drug delivery by increasing inhalation and actuation. Spacers with metered dose inhalers are used to treat several respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis.
The global asthma spacers market is expected to expand at a CAGR of 3.7% from 2018 to 2026. Technological advancements in spacer devices is likely to propel the market in the near future. Use of spacers/valve holding chambers minimizes issues related to the inhalation technique. It reduces oropharyngeal deposition and increases lung deposition, which, in turn, boosts the adoption of asthma spacers for the proper management of asthma. According to the WHO, around 235 million people are affected by asthma, and by the end of 2025, the number is likely to rise by 100 million globally.
Rise in the prevalence rate of asthma is creating a significant socioeconomic impact across the globe, which, in turn, is propelling the demand for asthma spacers. Inhalation is the first line administration route for asthma management. Nebulizers and metered dose inhalers are widely used for the management of asthma. Key players profiled in this report are Koninklijke Philips N.V, Trudell Medical International, Medical Development International, Merck & Co., Pari Gmbh, AstraZeneca, and GlaxoSmithKline plc. Companies operating in the global asthma spacers market focus on strategic collaborations to develop new products in the emerging regions such as Asia Pacific and Latin America.
To know more about us, please visit our website www.transparencymarketresearch.com For sales queries or new topics email us on: sales@transparencymarketresearch.com Thank You